CN107853396B - Method for preparing goat milk active beverage by using lactobacillus rhamnosus protease - Google Patents

Method for preparing goat milk active beverage by using lactobacillus rhamnosus protease Download PDF

Info

Publication number
CN107853396B
CN107853396B CN201710963850.5A CN201710963850A CN107853396B CN 107853396 B CN107853396 B CN 107853396B CN 201710963850 A CN201710963850 A CN 201710963850A CN 107853396 B CN107853396 B CN 107853396B
Authority
CN
China
Prior art keywords
lactobacillus rhamnosus
goat milk
muramidase
hovenia dulcis
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710963850.5A
Other languages
Chinese (zh)
Other versions
CN107853396A (en
Inventor
舒国伟
田梦琪
上官文菲
陈合
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaanxi Yatai Dairy Co ltd
Original Assignee
Shaanxi University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaanxi University of Science and Technology filed Critical Shaanxi University of Science and Technology
Priority to CN201710963850.5A priority Critical patent/CN107853396B/en
Publication of CN107853396A publication Critical patent/CN107853396A/en
Application granted granted Critical
Publication of CN107853396B publication Critical patent/CN107853396B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/152Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/156Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A23C9/1209Proteolytic or milk coagulating enzymes, e.g. trypsine
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C2220/00Biochemical treatment
    • A23C2220/10Enzymatic treatment
    • A23C2220/104Enzymatic treatment with immobilised enzymes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A method for preparing goat milk active beverage by Lactobacillus rhamnosus protease comprises inoculating Lactobacillus rhamnosus inoculum size into Lactobacillus rhamnosus culture medium, culturing, centrifuging, collecting thallus precipitate, washing with sterile normal saline, and centrifuging to obtain Lactobacillus rhamnosus bacterial mud; adding a phosphate buffer solution into the lactobacillus rhamnosus bacterial mud, centrifuging to obtain an enzyme solution of muramidase, and freeze-drying to obtain lactobacillus rhamnosus muramidase bacterial powder; adding Lactobacillus rhamnosus muramidase powder and CaCl into defatted fresh goat milk2After enzymolysis, beta-cyclodextrin, hovenia dulcis thunb polysaccharide, erythritol, xylitol, L-malic acid, citric acid and sodium citrate are added, and after uniform mixing and sterilization, the goat milk active beverage containing antihypertensive peptide and antioxidant peptide is obtained, wherein the ACE inhibitory activity is 70-90%, the DPPH free radical scavenging rate is 60-80%, and the hydroxyl free radical scavenging rate is 75-95%. The goat milk active beverage prepared by the invention takes goat milk as a raw material, and can be used as a food for assisting in reducing blood pressure, resisting oxidation, reducing blood sugar and preventing dental caries.

Description

Method for preparing goat milk active beverage by using lactobacillus rhamnosus protease
Technical Field
The invention relates to a preparation method of a functional goat milk beverage, in particular to a method for preparing a goat milk active beverage by using lactobacillus rhamnosus protease.
Background
Probiotics have proteolytic systems including CEP, aminopeptidases, endopeptidases, Pro-specific peptidases, etc., which hydrolyze proteins and release peptides of varying sizes and some free amino acids to meet the needs of bacterial growth, wherein some peptides produced by hydrolysis have biological activities such as antioxidant, hypotensive, immunomodulating, etc. Muramidase is the most important enzyme in the whole hydrolysis process, and several CEPs alone have been found to hydrolyze milk protein and produce ACE inhibitory peptides.
The cell surface of lactobacilli comprises a number of enzymes and proteins, mainly ribosomal proteinsLeukocytes, cell surface permeases, proteins of the surface layer (S-layer), cell membrane associated proteases (CEPs), and other protein-based molecules[10]. The mechanism of cell wall protease (CEP) hydrolysis of milk proteins is: firstly, milk protein is hydrolyzed into a series of short peptides by CEP, then the short peptides are transported into cells by oligopeptide, dipeptide and tripeptide transport systems, and finally the short peptides are further hydrolyzed into bioactive peptides such as ACE inhibitory peptide and antioxidant peptide by intracellular peptidase (endopeptidase, pro-specific peptidase, aminopeptidase and the like)
Hovenia dulcis, also called pawpaw, is named as Hovenia dulcis, and the polysaccharide of Hovenia dulcis has the function of reducing blood sugar, but the problem of low purity exists in the existing Hovenia dulcis polysaccharide preparation, and the main impurities are monosaccharide and disaccharide, so that the removal of monosaccharide and disaccharide and the retention of polysaccharide are the keys for preparing high-purity Hovenia dulcis polysaccharide and developing new products.
Shanxi province is the traditional main production area of milk goats in China, and the Guanzhong region is the largest production base of fine milk goat varieties in China. 180 million milk goats are stored in a whole province at the end of 2015, the goat milk yield is more than 50 million tons, the market share of the goat milk powder reaches more than 95%, the number of the milk goats, the goat milk yield and the goat milk powder yield are all the first nationwide, but the domestic goat milk products are few in variety and mainly comprise goat milk powder and liquid goat milk, most of the goat milk powder is sold abroad as industrial raw materials, and the problems of low technological content, low additional value, serious homogenization and the like exist, and the foreign goat milk products are various and mainly comprise fermented goat milk products (such as cheese, skim milk cheese or goat yogurt), frozen products (such as ice cream or frozen goat milk yogurt), liquid milk, butter, functional goat milk tablets and the like. Therefore, there is a need to develop new products of functional goat milk.
Disclosure of Invention
The invention aims to provide a method for preparing a goat milk active beverage by using lactobacillus rhamnosus protease with the functions of reducing blood pressure, resisting oxidation, reducing blood sugar, preventing decayed teeth and the like.
In order to achieve the purpose, the invention adopts the technical scheme that:
1) preparation of lactobacillus rhamnosus culture medium:
adding 15-25g of lactose, 15-25g of beef extract, 10-20mg of magnesium sulfate, 800.5-1.0 mL of tween, 2-5g of galactooligosaccharide, 3-6g of peptone, 4-6g of disodium hydrogen phosphate and 5-10mg of alanine into purified water, fixing the volume to 1L, adjusting the pH value to 5.5-7.0, and sterilizing at 121 ℃ to obtain a rhamnose lactobacillus culture medium;
2) culturing lactobacillus rhamnosus and collecting thalli:
inoculating lactobacillus rhamnosus into a lactobacillus rhamnosus culture medium according to the inoculation amount of 2-5%, culturing at constant temperature of 35-41 ℃ for 18-24h, centrifuging to collect thallus precipitate, washing with sterile normal saline, and centrifuging to obtain lactobacillus rhamnosus bacterial sludge;
3) preparation of lactobacillus rhamnosus muramidase:
adding 20-30mL of phosphate buffer solution into per g of lactobacillus rhamnosus bacterial mud, preserving heat at 35-45 ℃ for 1-3h, centrifuging to obtain supernatant, namely enzyme solution of muramidase, removing small molecular substances by using a 1-3KDa ultrafiltration membrane, and adding CaCl into the retention solution2Controlling CaCl2The concentration of the lactobacillus rhamnosus is 10-20mM, and freeze drying is carried out to obtain lactobacillus rhamnosus muramidase powder;
4) preparing the goat milk active beverage:
defatting fresh goat milk, adjusting pH to 6.0-8.0 mass volume ratio, adding 1-3% Lactobacillus rhamnosus muramidase powder and 0.01-0.04% CaCl2Carrying out enzymolysis at 35-45 ℃ for 2-4h, then adding 0.5-1.0% of beta-cyclodextrin, 0.2-0.4% of hovenia dulcis thunb polysaccharide, 4-6% of erythritol, 3-5% of xylitol, 0.1-0.3% of L-malic acid, 0.10-0.25% of citric acid and 0.10-0.25% of sodium citrate according to the mass-volume ratio, uniformly mixing, homogenizing and sterilizing to obtain the goat milk active beverage containing antihypertensive peptide and antioxidant peptide, wherein the ACE inhibitory activity of the goat milk active beverage is 70-90%, the DPPH free radical scavenging rate is 60-80%, and the hydroxyl free radical scavenging rate is 75-95%.
The centrifugation in the step 2) is carried out for 15-25min at 4-10 ℃ and 6000-8000 r/min.
The pH value of the phosphate buffer solution of the step 3) is 7.0, and each liter of the phosphate buffer solution contains 15-30g of glycine and 0.5-1.0g of lysozyme.
The centrifugation in the step 3) is carried out for 20-30min at 4-10 ℃ and 6000-8000 r/min.
The homogenization in the step 4) is carried out at the temperature of 15-30 ℃.
The preparation process of the hovenia dulcis polysaccharide in the step 4) comprises the following steps: cleaning fresh hovenia dulcis, pulping, adding water with the weight being 20 times that of hovenia dulcis, uniformly stirring, preserving heat for 2 hours at 90 ℃, carrying out suction filtration to obtain hovenia dulcis polysaccharide extracting solution, cooling to 38 ℃, adding 2% of a bailadi yeast activating solution according to the mass-volume ratio, carrying out constant-temperature culture for 24 hours at 37 ℃, removing monosaccharide and disaccharide in the hovenia dulcis, centrifugally collecting the bailadi yeast thalli, concentrating the supernatant to 1/20 by using a rotary evaporator, adding absolute ethyl alcohol according to the volume ratio of 1:3, carrying out suction filtration by using a Buchner funnel to obtain hovenia dulcis crude polysaccharide, adding the hovenia crude polysaccharide into chloroform and n-butyl alcohol for deproteinization, adding chloroform and n-butyl alcohol into the hovenia dulcis crude polysaccharide again, taking water for deproteinization, and carrying out freeze drying to obtain the hovenia polysaccharide.
According to the invention, goat milk is taken as a raw material, cell wall protease of GRAS microorganism-lactobacillus rhamnosus is taken as a biocatalyst, protein in the goat milk is hydrolyzed into short peptide with ACE inhibitory activity and oxidation resistance, a consumer can take the short peptide to assist in reducing blood pressure and resisting oxidation, the added hovenia dulcis polysaccharide has the functions of a stabilizer and reducing blood sugar, and the functionality of the goat milk active beverage can be improved; the added erythritol and xylitol are functional sugar alcohols, and have the characteristics of low sweetness, low calorie, no decayed tooth, small influence on blood sugar and the like.
Detailed Description
The present invention will be described in further detail with reference to specific examples.
Example 1:
1) preparation of lactobacillus rhamnosus culture medium:
adding 20g of lactose, 15g of beef extract, 13mg of magnesium sulfate, 800.7 mL of tween, 3g of galacto-oligosaccharide, 3g of peptone, 6g of disodium hydrogen phosphate and 5mg of alanine into purified water, metering the volume to 1L, adjusting the pH value to 6.0, and sterilizing at 121 ℃ to obtain a lactobacillus rhamnosus culture medium;
2) culturing lactobacillus rhamnosus and collecting thalli:
inoculating lactobacillus rhamnosus into a lactobacillus rhamnosus culture medium according to the inoculation amount of 3%, culturing at the constant temperature of 37 ℃ for 22h, centrifuging to collect thallus precipitates, washing with sterile normal saline, and centrifuging to obtain lactobacillus rhamnosus bacterial sludge;
the centrifugation is carried out for 20min at 8 ℃ and 7000 r/min;
3) preparation of lactobacillus rhamnosus muramidase:
adding 23mL of phosphate buffer solution with pH of 7.0 (20 g glycine and 1.0g lysozyme in each liter of phosphate buffer solution) into each g of lactobacillus rhamnosus bacterial sludge, keeping the temperature at 35 ℃ for 3h, centrifuging at 4 ℃ and 8000r/min for 20min to obtain supernatant, namely enzyme solution of muramidase, removing small molecular substances by using a 1-3KDa ultrafiltration membrane, and adding CaCl and CaCl into the retention solution2Controlling CaCl2The concentration of the lactobacillus rhamnosus is 17mM, and freeze drying is carried out to obtain lactobacillus rhamnosus muramidase powder;
4) preparing the goat milk active beverage:
defatting fresh goat milk, adjusting pH to 6.5 mass volume ratio, adding 1.5% Lactobacillus rhamnosus muramidase powder and 0.03% CaCl2Carrying out enzymolysis for 3h at 40 ℃, then adding 0.8% of beta-cyclodextrin, 0.2% of hovenia dulcis thunb polysaccharide, 5% of erythritol, 5% of xylitol, 0.3% of L-malic acid, 0.2% of citric acid and 0.15% of sodium citrate according to the mass-volume ratio, uniformly mixing, homogenizing at 25 ℃, and sterilizing to obtain the goat milk active beverage containing the antihypertensive peptide and the antioxidant peptide, wherein the ACE inhibitory activity of the goat milk active beverage is 80%, the DPPH free radical scavenging rate is 60%, and the hydroxyl free radical scavenging rate is 75%.
Example 2:
1) preparation of lactobacillus rhamnosus culture medium:
adding 15g of lactose, 20g of beef extract, 18mg of magnesium sulfate, 800.5 mL of tween, 4g of galacto-oligosaccharide, 5g of peptone, 4g of disodium hydrogen phosphate and 8mg of alanine into purified water, diluting to a constant volume of 1L, adjusting the pH value to 5.5, and sterilizing at 121 ℃ to obtain a lactobacillus rhamnosus culture medium;
2) culturing lactobacillus rhamnosus and collecting thalli:
inoculating lactobacillus rhamnosus into a lactobacillus rhamnosus culture medium according to the inoculation amount of 5%, culturing at constant temperature of 35 ℃ for 24h, centrifuging to collect thallus precipitates, washing with sterile normal saline, and centrifuging to obtain lactobacillus rhamnosus bacterial sludge;
the centrifugation is carried out for 15min at the temperature of 4 ℃ and at the speed of 8000 r/min;
3) preparation of lactobacillus rhamnosus muramidase:
adding 30mL of phosphate buffer solution with pH of 7.0 (each liter of phosphate buffer solution contains 15g of glycine and 0.8g of lysozyme) into each g of lactobacillus rhamnosus bacterial sludge, preserving heat at 40 ℃ for 2h, centrifuging at 8 ℃ and 7000r/min for 5min to obtain supernatant, namely enzyme solution of muramidase, removing small molecular substances by using a 1-3KDa ultrafiltration membrane, and adding CaCl and CaCl into the retention solution2Controlling CaCl2The concentration of the lactobacillus rhamnosus is 17mM, and freeze drying is carried out to obtain lactobacillus rhamnosus muramidase powder;
4) preparing the goat milk active beverage:
defatting fresh goat milk, adjusting pH to 6.0 mass volume ratio, adding 3% Lactobacillus rhamnosus muramidase powder and 0.01% CaCl2Carrying out enzymolysis at 35 ℃ for 4h, then adding 0.5% of beta-cyclodextrin, 0.4% of hovenia dulcis thunb polysaccharide, 4% of erythritol, 3% of xylitol, 0.1% of L-malic acid, 0.15% of citric acid and 0.10% of sodium citrate according to the mass-volume ratio, uniformly mixing, homogenizing at 15 ℃, and sterilizing to obtain the goat milk active beverage containing antihypertensive peptide and antioxidant peptide, wherein the ACE inhibitory activity of the goat milk active beverage is 70%, the DPPH free radical scavenging rate is 80%, and the hydroxyl free radical scavenging rate is 85%.
Example 3:
1) preparation of lactobacillus rhamnosus culture medium:
adding 25g of lactose, 20g of beef extract, 20mg of magnesium sulfate, 801.0 mL of tween, 2g of galacto-oligosaccharide, 6g of peptone, 5g of disodium hydrogen phosphate and 10mg of alanine into purified water, metering the volume to 1L, adjusting the pH value to 6.5, and sterilizing at 121 ℃ to obtain a lactobacillus rhamnosus culture medium;
2) culturing lactobacillus rhamnosus and collecting thalli:
inoculating lactobacillus rhamnosus into a lactobacillus rhamnosus culture medium according to the inoculation amount of 2%, culturing at the constant temperature of 39 ℃ for 20h, centrifuging to collect thallus precipitates, washing with sterile normal saline, and centrifuging to obtain lactobacillus rhamnosus bacterial sludge;
the centrifugation is carried out for 25min at 10 ℃ and 6000 r/min;
3) preparation of lactobacillus rhamnosus muramidase:
adding 28mL of phosphate buffer solution with pH of 7.0 (30 g glycine and 0.5g lysozyme in each liter of phosphate buffer solution) into per g of lactobacillus rhamnosus bacterial sludge, keeping the temperature at 45 ℃ for 1h, centrifuging at 6 ℃ and 6000r/min for 30min to obtain supernatant, namely enzyme solution of muramidase, removing small molecular substances by using a 1-3KDa ultrafiltration membrane, and adding CaCl and CaCl into the retention solution2Controlling CaCl2The concentration of the lactobacillus rhamnosus is 20mM, and freeze drying is carried out to obtain lactobacillus rhamnosus muramidase powder;
4) preparing the goat milk active beverage:
defatting fresh goat milk, adjusting pH to 8.0 mass volume ratio, adding 1% Lactobacillus rhamnosus muramidase powder and 0.04% CaCl2Carrying out enzymolysis for 2h at 45 ℃, then adding 1.0% of beta-cyclodextrin, 0.3% of hovenia dulcis thunb polysaccharide, 6% of erythritol, 5% of xylitol, 0.2% of L-malic acid, 0.10% of citric acid and 0.25% of sodium citrate according to the mass-volume ratio, uniformly mixing, homogenizing at 30 ℃, and sterilizing to obtain the goat milk active beverage containing antihypertensive peptide and antioxidant peptide, wherein the ACE inhibitory activity of the goat milk active beverage is 90%, the DPPH free radical scavenging rate is 75%, and the hydroxyl free radical scavenging rate is 95%.
Example 4:
1) preparation of lactobacillus rhamnosus culture medium:
adding 18g of lactose, 22g of beef extract, 10mg of magnesium sulfate, 800.8 mL of tween, 5g of galacto-oligosaccharide, 4g of peptone, 4g of disodium hydrogen phosphate and 6mg of alanine into purified water, diluting to 1L, adjusting the pH value to 7.0, and sterilizing at 121 ℃ to obtain a lactobacillus rhamnosus culture medium;
2) culturing lactobacillus rhamnosus and collecting thalli:
inoculating lactobacillus rhamnosus into a lactobacillus rhamnosus culture medium according to the inoculation amount of 4%, culturing at constant temperature of 41 ℃ for 18h, centrifuging to collect thallus precipitates, washing with sterile normal saline, and centrifuging to obtain lactobacillus rhamnosus bacterial sludge;
the centrifugation is carried out for 18min at the temperature of 6 ℃ and at the speed of 8000 r/min;
3) preparation of lactobacillus rhamnosus muramidase:
adding 20mL of phosphate buffer solution with pH of 7.0 (25 g glycine and 0.6g lysozyme in each liter of phosphate buffer solution) into per g of lactobacillus rhamnosus bacterial sludge, keeping the temperature at 38 ℃ for 3h, centrifuging at 10 ℃ and 6000r/min for 28min to obtain supernatant, namely enzyme solution of muramidase, removing small molecular substances by using a 1-3KDa ultrafiltration membrane, and adding CaCl and CaCl into the retention solution2Controlling CaCl2The concentration of the lactobacillus rhamnosus is 10mM, and freeze drying is carried out to obtain rhamnose lactobacillus muramidase powder;
4) preparing the goat milk active beverage:
defatting fresh goat milk, adjusting pH to 7.0 mass volume ratio, adding 2% Lactobacillus rhamnosus muramidase powder and 0.02% CaCl2Carrying out enzymolysis at 42 ℃ for 3h, then adding 0.6% of beta-cyclodextrin, 0.4% of hovenia dulcis thunb polysaccharide, 5% of erythritol, 4% of xylitol, 0.1% of L-malic acid, 0.25% of citric acid and 0.20% of sodium citrate according to the mass-volume ratio, uniformly mixing, homogenizing at 20 ℃, and sterilizing to obtain the goat milk active beverage containing antihypertensive peptide and antioxidant peptide, wherein the ACE inhibitory activity of the goat milk active beverage is 85%, the DPPH free radical scavenging rate is 70%, and the hydroxyl free radical scavenging rate is 90%.
The hovenia dulcis thunb polysaccharide in the embodiment is prepared by the following method: cleaning fresh hovenia dulcis, pulping, adding water with the weight being 20 times that of hovenia dulcis, uniformly stirring, preserving heat for 2 hours at 90 ℃, carrying out suction filtration to obtain hovenia dulcis polysaccharide extracting solution, cooling to 38 ℃, adding 2% of a bailadi yeast activating solution according to the mass-volume ratio, carrying out constant-temperature culture for 24 hours at 37 ℃, removing monosaccharide and disaccharide in the hovenia dulcis, centrifugally collecting the bailadi yeast thalli, concentrating the supernatant to 1/20 by using a rotary evaporator, adding absolute ethyl alcohol according to the volume ratio of 1:3, carrying out suction filtration by using a Buchner funnel to obtain hovenia dulcis crude polysaccharide, adding the hovenia crude polysaccharide into chloroform and n-butyl alcohol for deproteinization, adding chloroform and n-butyl alcohol into the hovenia dulcis crude polysaccharide again, taking water for deproteinization, and carrying out freeze drying to obtain the hovenia polysaccharide.

Claims (6)

1. A method for preparing goat milk active beverage by lactobacillus rhamnosus protease is characterized in that:
1) preparation of lactobacillus rhamnosus culture medium:
adding 15-25g of lactose, 15-25g of beef extract, 10-20mg of magnesium sulfate, 800.5-1.0 mL of tween, 2-5g of galactooligosaccharide, 3-6g of peptone, 4-6g of disodium hydrogen phosphate and 5-10mg of alanine into purified water, fixing the volume to 1L, adjusting the pH value to 5.5-7.0, and sterilizing at 121 ℃ to obtain a rhamnose lactobacillus culture medium;
2) culturing lactobacillus rhamnosus and collecting thalli:
inoculating lactobacillus rhamnosus into a lactobacillus rhamnosus culture medium according to the inoculation amount of 2-5%, culturing at constant temperature of 35-41 ℃ for 18-24h, centrifuging to collect thallus precipitate, washing with sterile normal saline, and centrifuging to obtain lactobacillus rhamnosus bacterial sludge;
3) preparation of lactobacillus rhamnosus muramidase:
adding 20-30mL of phosphate buffer solution into per g of lactobacillus rhamnosus bacterial mud, preserving heat at 35-45 ℃ for 1-3h, centrifuging to obtain supernatant, namely enzyme solution of muramidase, removing small molecular substances by using a 1-3KDa ultrafiltration membrane, and adding CaCl into the retention solution2Controlling CaCl2The concentration of the lactobacillus rhamnosus is 10-20mM, and freeze drying is carried out to obtain lactobacillus rhamnosus muramidase powder;
4) preparing the goat milk active beverage:
defatting fresh goat milk, adjusting pH to 6.0-8.0 mass volume ratio, adding 1-3% Lactobacillus rhamnosus muramidase powder and 0.01-0.04% CaCl2Carrying out enzymolysis at 35-45 ℃ for 2-4h, then adding 0.5-1.0% of beta-cyclodextrin, 0.2-0.4% of hovenia dulcis thunb polysaccharide, 4-6% of erythritol, 3-5% of xylitol, 0.1-0.3% of L-malic acid, 0.10-0.25% of citric acid and 0.10-0.25% of sodium citrate according to the mass-volume ratio, uniformly mixing, homogenizing and sterilizing to obtain the goat milk active beverage containing the antihypertensive peptide and the antioxidant peptide, wherein the ACE inhibitory activity of the goat milk active beverage is 70-90%, the DPPH free radical scavenging rate is 60-80%,the hydroxyl radical clearance rate is 75-95%.
2. Method for the preparation of a goat milk active drink with lactobacillus rhamnosus protease according to claim 1 characterized by: the centrifugation in the step 2) is carried out for 15-25min at 4-10 ℃ and 6000-8000 r/min.
3. Method for the preparation of a goat milk active drink with lactobacillus rhamnosus protease according to claim 1 characterized by: the pH value of the phosphate buffer solution of the step 3) is 7.0, and each liter of the phosphate buffer solution contains 15-30g of glycine and 0.5-1.0g of lysozyme.
4. Method for the preparation of a goat milk active drink with lactobacillus rhamnosus protease according to claim 1 characterized by: the centrifugation in the step 3) is carried out for 20-30min at 4-10 ℃ and 6000-8000 r/min.
5. Method for the preparation of a goat milk active drink with lactobacillus rhamnosus protease according to claim 1 characterized by: the homogenization in the step 4) is carried out at the temperature of 15-30 ℃.
6. Method for the preparation of a goat milk active drink with lactobacillus rhamnosus protease according to claim 1 characterized by: the preparation process of the hovenia dulcis polysaccharide in the step 4) comprises the following steps: cleaning fresh hovenia dulcis, pulping, adding water with the weight being 20 times that of hovenia dulcis, uniformly stirring, preserving heat for 2 hours at 90 ℃, carrying out suction filtration to obtain hovenia dulcis polysaccharide extracting solution, cooling to 38 ℃, adding 2% of a bailadi yeast activating solution according to the mass-volume ratio, carrying out constant-temperature culture for 24 hours at 37 ℃, removing monosaccharide and disaccharide in the hovenia dulcis, centrifugally collecting the bailadi yeast thalli, concentrating the supernatant to 1/20 by using a rotary evaporator, adding absolute ethyl alcohol according to the volume ratio of 1:3, carrying out suction filtration by using a Buchner funnel to obtain hovenia dulcis crude polysaccharide, adding the hovenia crude polysaccharide into chloroform and n-butyl alcohol for deproteinization, adding chloroform and n-butyl alcohol into the hovenia dulcis crude polysaccharide again, taking water for deproteinization, and carrying out freeze drying to obtain the hovenia polysaccharide.
CN201710963850.5A 2017-10-17 2017-10-17 Method for preparing goat milk active beverage by using lactobacillus rhamnosus protease Active CN107853396B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710963850.5A CN107853396B (en) 2017-10-17 2017-10-17 Method for preparing goat milk active beverage by using lactobacillus rhamnosus protease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710963850.5A CN107853396B (en) 2017-10-17 2017-10-17 Method for preparing goat milk active beverage by using lactobacillus rhamnosus protease

Publications (2)

Publication Number Publication Date
CN107853396A CN107853396A (en) 2018-03-30
CN107853396B true CN107853396B (en) 2020-12-01

Family

ID=61698856

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710963850.5A Active CN107853396B (en) 2017-10-17 2017-10-17 Method for preparing goat milk active beverage by using lactobacillus rhamnosus protease

Country Status (1)

Country Link
CN (1) CN107853396B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109161496A (en) * 2018-08-19 2019-01-08 东北农业大学 Lactobacillus rhamnosus high density bacterium solution and its preparation method for embedding bacterium powder
CN113186176B (en) * 2021-04-22 2023-04-04 华东理工大学 Method for producing rhizomucor miehei lipase by total synthesis culture medium and fermentation method
CN113755365B (en) * 2021-08-11 2024-02-27 天津科技大学 Preparation method and application of lactobacillus extract
CN114903083B (en) * 2022-06-09 2023-10-20 西安百跃羊乳集团有限公司 Bioactive peptide probiotic fermented sheep milk and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101019577A (en) * 2007-03-16 2007-08-22 陕西科技大学 Production process of rhamnose lactobacillus milk powder
CN101700072A (en) * 2009-11-13 2010-05-05 宁波大学 Method for producing low-lactose milk beverage
CN102477104A (en) * 2010-11-25 2012-05-30 苏州宝泽堂医药科技有限公司 Method for separating and purifying polysaccharide from Hovenia acerba
CN103211024A (en) * 2013-04-16 2013-07-24 陕西科技大学 Method for preparing goat milk beverage containing ACE (Angiotensin Converting Enzyme) inhibitory peptide
CN106417601A (en) * 2016-09-23 2017-02-22 陕西科技大学 Preparation method of antioxidant peptide-containing probiotics milk beverage
CN106665858A (en) * 2016-12-30 2017-05-17 陕西师范大学 Green tea goat milk with function of reducing blood pressure and preparation method of green tea goat milk

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101019577A (en) * 2007-03-16 2007-08-22 陕西科技大学 Production process of rhamnose lactobacillus milk powder
CN101700072A (en) * 2009-11-13 2010-05-05 宁波大学 Method for producing low-lactose milk beverage
CN102477104A (en) * 2010-11-25 2012-05-30 苏州宝泽堂医药科技有限公司 Method for separating and purifying polysaccharide from Hovenia acerba
CN103211024A (en) * 2013-04-16 2013-07-24 陕西科技大学 Method for preparing goat milk beverage containing ACE (Angiotensin Converting Enzyme) inhibitory peptide
CN106417601A (en) * 2016-09-23 2017-02-22 陕西科技大学 Preparation method of antioxidant peptide-containing probiotics milk beverage
CN106665858A (en) * 2016-12-30 2017-05-17 陕西师范大学 Green tea goat milk with function of reducing blood pressure and preparation method of green tea goat milk

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
发酵羊乳产抗氧化肽乳杆菌的筛选及产肽条件优化;惠翌昕;《中国优秀硕士学位论文全文数据库》;20161231;第6-9、16-17页 *
胞壁蛋白酶(CEP)酶解对酪蛋白结构及功能特性的影响;任晓芬等;《现代食品科技》;20131115(第11期);第2643-2648页 *
酵母发酵法提纯地木耳粗多糖的工艺优化;朱双杰等;《食品与生物技术学报》;20121115(第11期);第65-68页 *

Also Published As

Publication number Publication date
CN107853396A (en) 2018-03-30

Similar Documents

Publication Publication Date Title
CA2387738C (en) Process for producing a product containing antihypertensive tripeptides
CN107853396B (en) Method for preparing goat milk active beverage by using lactobacillus rhamnosus protease
CN103243144B (en) Collagen powder rich in collagen tripeptide and preparation method thereof
CN101492663B (en) Fermentation preparation and extraction method for bacillus subtilis debitterized aminopeptidase
CN101925674A (en) Improved biologically active peptides production
JP4332247B2 (en) A lactic acid bacterium having high ability to produce γ-aminobutyric acid, a fermented food containing a high amount of γ-aminobutyric acid using the lactic acid bacterium, and a method for producing the same.
CLEGG et al. Dietary enzymic hydrolysates of protein with reduced bitterness
CN109880874A (en) A kind of preparation method of rice active peptide, rice active peptide and its application
JP4115181B2 (en) Method for enhancing immunostimulatory effect of lactic acid bacteria
CN114680337B (en) Application of lactobacillus helveticus in preparation of antihypertensive fermentation product
US10023617B1 (en) Methods and systems of producing pharmaceutical grade lantibiotics
CN107853394B (en) Method for preparing goat milk active beverage by using lactobacillus bulgaricus muramidase
US20050142166A1 (en) Peptides with anti-hypertensive properties
CN112143767A (en) Method for preparing perinereis aibuhitensis protein source ACE inhibitory peptide
CN111909978B (en) Method for directionally preparing hydrolysate rich in LPP from corn protein powder by using fermentation method
CN114317657B (en) Fishbone peptide and preparation method and application thereof
CN108576218A (en) A kind of method that Roy formula lactobacillus protease prepares the breast active beverage of sheep containing Antihypertensive Peptides
CN117660420B (en) Microbacterium chymosin and application thereof
JPH0797973B2 (en) Natural beef concentrated juice flavor enhancement method
CN114317657A (en) Fishbone peptide and preparation method and application thereof
CN116694515A (en) Lactobacillus helveticus AH071113 and application thereof in preparing yoghourt product by fermenting cow milk
KR100295872B1 (en) Manufacturing method of fermented milk having inhibitory effect on angiotensin converting enzyme
CN116162678A (en) Collagen peptide and preparation method and application thereof
CN114921513A (en) Method for preparing hemp protein peptide by combined solid state fermentation of lactic acid bacteria and psychrophile protease
CN112322682A (en) Method for preparing bitter-free plant oligopeptide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20221021

Address after: 713701 Wangqiao Town, Jingyang County, Xi'an, Shaanxi

Patentee after: SHAANXI YATAI DAIRY CO.,LTD.

Address before: 710021 Shaanxi province Xi'an Weiyang university campus of Shaanxi University of Science and Technology

Patentee before: SHAANXI University OF SCIENCE & TECHNOLOGY